Income after Taxes: Earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Can-Fite Biopharma Ltd (CANF) Income after Taxes data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Income after Taxes |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$8.00M |
|
$0.01M |
|
$0.05M |
|
$8.05M |
|
$2.23M |
|
-- |
|
$0.97M |
|
$3.20M |
|
$4.86M |
|
$4.86M |
|
$4.86M |
|
2.14M |
|
| Cash Flow Statement Financials | |
$-5.31M |
|
$-1.00M |
|
$3.77M |
|
$5.53M |
|
$2.98M |
|
$-2.54M |
|
$0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|